Matthew Campbell to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Matthew Campbell has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.340
-
An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial. Diab Vasc Dis Res. 2017 07; 14(4):336-344.
Score: 0.126
-
The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. Cardiovasc Diabetol. 2015 Jun 05; 14:71.
Score: 0.111
-
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial. PLoS One. 2014; 9(5):e97143.
Score: 0.103